Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

TARGETED THERAPIES

Taking the STING out of inflammation

Stimulator of interferon genes (STING), an important component of the cytosolic DNA sensing pathway, is an attractive therapeutic target for ameliorating interferon-driven systemic inflammation. New findings are shedding light on how STING functions and on a strategy to target STING therapeutically.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: The sensing of cytosolic DNA by the cGAS–STING pathway.

References

  1. Hartmann, G. Nucleic acid immunity. Adv. Immunol. 133, 121–169 (2017).

    Article  PubMed  CAS  Google Scholar 

  2. Haag, S. M. et al. Targeting STING with covalent small-molecule inhibitors. Nature 559, 269–273 (2018).

    Article  PubMed  CAS  Google Scholar 

  3. Rodero, M. P. & Crow, Y. J. Type I interferon-mediated monogenic autoinflammation: the type I interferonopathies, a conceptual overview. J. Exp. Med. 213, 2527–2538 (2016).

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  4. Li, T. & Chen, Z. J. The cGAS-cGAMP-STING pathway connects DNA damage to inflammation, senescence, and cancer. J. Exp. Med. 215, 1287–1299 (2018).

    Article  PubMed  CAS  Google Scholar 

  5. King, K. R. et al. IRF3 and type I interferons fuel a fatal response to myocardial infarction. Nat. Med. 23, 1481–1487 (2017).

    Article  PubMed  CAS  Google Scholar 

  6. Kerur, N. et al. cGAS drives noncanonical-inflammasome activation in age-related macular degeneration. Nat. Med. 24, 50–61 (2018).

    Article  PubMed  CAS  Google Scholar 

  7. Gao, D. et al. Activation of cyclic GMP-AMP synthase by self-DNA causes autoimmune diseases. Proc. Natl Acad. Sci. USA 112, E5699–E5705 (2015).

    Article  PubMed  CAS  Google Scholar 

  8. Sharma, S. et al. Suppression of systemic autoimmunity by the innate immune adaptor STING. Proc. Natl Acad. Sci. USA 112, E710–E717 (2015).

    Article  PubMed  CAS  Google Scholar 

  9. Mathur, V. et al. Activation of the STING-dependent type I interferon response reduces microglial reactivity and neuroinflammation. Neuron 96, 1290–1302 (2017).

    Article  PubMed  CAS  Google Scholar 

  10. Freischmidt, A. et al. Haploinsufficiency of TBK1 causes familial ALS and fronto-temporal dementia. Nat. Neurosci. 18, 631–636 (2015).

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgements

Y.J.C. acknowledges the European Research Council (GA 309449 and 786142-E-T1IFNs), ERA-NET Neuron (MR/M501803/1) and a state subsidy managed by the National Research Agency (France) under the “Investments for the Future” programme bearing the reference ANR-10-IAHU-01.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Yanick J. Crow.

Ethics declarations

Competing interests

The authors declare no competing interests.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Uggenti, C., Crow, Y.J. Taking the STING out of inflammation. Nat Rev Rheumatol 14, 508–509 (2018). https://doi.org/10.1038/s41584-018-0071-z

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41584-018-0071-z

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing